Editor's Page: The Future of the Journal of Cardiac Failure: A Reinvigorated Focus on People, Partnerships and Presentation. @dranulala @robmentz

Do warmer 🔥☀️ temperatures ⬆️ risk of driveline infections?🚨 . 📌DLIs affect 40% of LVAD pts at 5 years .📌DLIs ⬆️mortality ⬆️ pump thrombosis & stroke, so prevention is 🔑 .📌Calì et al found ⬆️ temperature = ⬆️ risk of DLIs . Read more👇 .🔗

PROs provide valuable insight into pts health status, but can they be used to improve risk prediction in HF?. 💡In this study, adding PROs to risk models improved ability to predict adverse events. How does your HF program utilize PRO assessments? . 🔗

Still thinking about submitting? Time is running out.⏳. There are only a few days left to submit your work to the Journal of Cardiac Failure Hemodynamics Focus Issue. Make your research count. Deadline is June 30th. 🫀. #HeartFailure #MedicalJournal

ICYMI: The 2024 Impact Factor released last week - we’re thrilled to say that JCF received 8.2, up from 6.7 in 2023. ❤️‍🔥. To us, impact is creating a community that moves the field forward, educating patients and colleagues, & amplifying voices from all corners of cardiology. 🌎

You’ve still got time - but not much! There are 2 weeks left to be part of the Journal of Cardiac Failure Hemodynamics Focus Issue. 🫀. If you're working in this space, we want to hear from you. 🔗. #JCFImpact #AcademicPublishing

People. Experience. Community. Since 2020, it's been how we measure impact at JCF. When numbers reflect our mission, it's even sweeter 💜. 🎉 JCF’s 2024 Impact Factor is ⬆️ 8.2 (from 6.7 in 2023). 🫀 Watch how we’re making a difference ⬇️. @Hfsa @robmentz @dranulala

📖 The June issue is here! . Catch up on the latest in heart failure research, reviews & more from the Journal of Cardiac Failure. 🔗 . #HeartFailure #Cardiology #JCF

RT @dranulala: I had to miss #HFA2025 in Belgrade to be home with kiddos. Luckily @JCardFail has got me covered with the #ICYMI series reca….

Calling all authors! ✍️ . There are only 4 weeks left to submit your work for the #JCF Hemodynamics Focus Issue. If your research advances the science of hemodynamics in heart failure, we want to hear from you. Submit your paper today:

A secondary analysis of the FINEARTS-HF trial examined the effect of finerenone vs. placebo on early readmissions in those randomized during/within 7 days of HHF. It showed that finerenone appeared to favorably influence risk of early HF readmissions. 🔗

To study HF RPM programs, a multinat'l (USA & India) single-arm trial of pts discharged following HHF was conducted. It showed that RPM ⬆️ NT-proBNP, KCCQ, 6MWT & GDMT utilization. This suggests a pathway to bridge the gap in post-HHF GDMT utilization. 🔗

Is uptitration of ARNI in stabilized hospitalized HF pts beneficial? Uptitration Rx led to greater ⬇️ NT-proBNP compared to ARNI w/o uptitration or ACEI/ARB after 8 weeks. In LVEF <40%, ARNI w/wo uptitration led to similar ⬇️ in NT-proBNP. 🔗

Steroidal & non-steroidal MRA & aldosterone synthase inhibitors (ASi) are clinically available & being tested in trials. This review evaluates the similarities/differences between these agents & advocates for head-to-head comparisons to guide clinicians.

⏳ Time is running out to apply for the JCF 2025–26 Reviewer Mentorship Program! . Open to early career clinicians in all specialties, including international applicants. Don't miss out! Applications due by tomorrow May 16th - no exceptions. 🔗

New month, new issue! . Explore the latest research, reviews, and insights shaping the future of heart failure care in #JCF's May Issue. 🫀 Start reading:

🖥️AI can play a key role in prev, early detection & treatment of HF, driven by advancements like multimodal LLMs. But challenges like data privacy, system integration, clinician trust & fairness/bias warrant further study. Read the latest Review:

The accompanying editorial outlines some of the challenges of integrating APC into the HF setting: 👩🏽‍⚕️Workforce constraints .💰Cost implications .💜Need for diverse interdisciplinary palliative care team . 🔗

Check out a new 🔥study that offers insight into successful implementation of ambulatory palliative care (APC) for patients w/ HF. Key points: .-Deploying APC champions .-Educating clinicians on the benefits of APC .-Standardized patient selection . 🔗

🫀 ICYMI: JCF is accepting applications for its 2025–26 Reviewer Mentorship Program! . ✔️ Early career clinicians .✔️ All specialties welcome .✔️ Open to international applicants 🌍 . Apply by May 16 (no extensions!) . 🔗

RT @robmentz: Don't let great research stall. With JCF Express: Court of Appeals you can submit your previously reviewed manuscript for an….